423 related articles for article (PubMed ID: 26880460)
1. Low parathyroid hormone status induced by high dialysate calcium is an independent risk factor for cardiovascular death in hemodialysis patients.
Merle E; Roth H; London GM; Jean G; Hannedouche T; Bouchet JL; Drüeke T; Fouque D; Daugas E;
Kidney Int; 2016 Mar; 89(3):666-74. PubMed ID: 26880460
[TBL] [Abstract][Full Text] [Related]
2. Low parathyroid hormone levels after parathyroidectomy reduce cardiovascular mortality in chronic hemodialysis patients.
Iwamoto N; Sato N; Nishida M; Hashimoto T; Kobayashi H; Yamazaki S; Okino K; Nishimura M; Takatani T; Okamoto Y; Nakanouchi T; Koyama M; Adachi N; Ninomiya K; Mabuchi H; Iseki K
Clin Exp Nephrol; 2016 Oct; 20(5):808-814. PubMed ID: 26677857
[TBL] [Abstract][Full Text] [Related]
3. Reduced Mortality in Maintenance Haemodialysis Patients on High versus Low Dialysate Magnesium: A Pilot Study.
Schmaderer C; Braunisch MC; Suttmann Y; Lorenz G; Pham D; Haller B; Angermann S; Matschkal J; Renders L; Baumann M; Braun JR; Heemann U; Küchle C
Nutrients; 2017 Aug; 9(9):. PubMed ID: 28832502
[TBL] [Abstract][Full Text] [Related]
4. High-calcium dialysate: a factor associated with inflammation, malnutrition and mortality in non-diabetic maintenance haemodialysis patients.
Hsu CW; Lin JL; Lin-Tan DT; Yen TH; Chen KH; Huang WH; Ho TC; Huang YL
Nephrology (Carlton); 2010 Apr; 15(3):313-20. PubMed ID: 20470300
[TBL] [Abstract][Full Text] [Related]
5. CKD-mineral and bone disorder and risk of death and cardiovascular hospitalization in patients on hemodialysis.
Block GA; Kilpatrick RD; Lowe KA; Wang W; Danese MD
Clin J Am Soc Nephrol; 2013 Dec; 8(12):2132-40. PubMed ID: 24052218
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the kinetics of the parathyroid hormone, and of associated patient outcomes, in a cohort of haemodialysis patients.
Jean G; Souberbielle JC; Zaoui E; Lorriaux C; Hurot JM; Mayor B; Deleaval P; Mehdi M; Chazot C
BMC Nephrol; 2016 Oct; 17(1):153. PubMed ID: 27756251
[TBL] [Abstract][Full Text] [Related]
7. Effects of lowering dialysate calcium concentration on mineral metabolism and hemodynamic parameters in hemodialysis patients.
Alayoud A; El Kabbaj D; Benyahia M; Asseraji M; Zemraoui N
Iran J Kidney Dis; 2015 Mar; 9(2):132-7. PubMed ID: 25851292
[TBL] [Abstract][Full Text] [Related]
8. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.
Tentori F; Wang M; Bieber BA; Karaboyas A; Li Y; Jacobson SH; Andreucci VE; Fukagawa M; Frimat L; Mendelssohn DC; Port FK; Pisoni RL; Robinson BM
Clin J Am Soc Nephrol; 2015 Jan; 10(1):98-109. PubMed ID: 25516917
[TBL] [Abstract][Full Text] [Related]
9. Facility Dialysate Calcium Practices and Clinical Outcomes Among Patients Receiving Hemodialysis: A Retrospective Observational Study.
Brunelli SM; Sibbel S; Do TP; Cooper K; Bradbury BD
Am J Kidney Dis; 2015 Oct; 66(4):655-65. PubMed ID: 26015274
[TBL] [Abstract][Full Text] [Related]
10. Comparison between different dialysate calcium concentrations in nocturnal hemodialysis.
Toussaint ND; Polkinghorne KR; Kerr PG; Somerville CA; Agar JW
Hemodial Int; 2007 Apr; 11(2):217-24. PubMed ID: 17403174
[TBL] [Abstract][Full Text] [Related]
11. Effects of Lowering Dialysate Calcium Concentration on Mineral and Bone Disorders in Chronic Hemodialysis Patients: Conversion from 3.0 mEq/L to 2.75 mEq/L.
Yamada S; Ueki K; Tokumoto M; Suehiro T; Kimura H; Taniguchi M; Fujimi S; Kitazono T; Tsuruya K
Ther Apher Dial; 2016 Feb; 20(1):31-9. PubMed ID: 26482334
[TBL] [Abstract][Full Text] [Related]
12. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Tentori F; Blayney MJ; Albert JM; Gillespie BW; Kerr PG; Bommer J; Young EW; Akizawa T; Akiba T; Pisoni RL; Robinson BM; Port FK
Am J Kidney Dis; 2008 Sep; 52(3):519-30. PubMed ID: 18514987
[TBL] [Abstract][Full Text] [Related]
13. Individualization of dialysate calcium concentration according to baseline pre-dialysis serum calcium.
Gonzalez-Parra E; Gonzalez-Casaus ML; Arenas MD; Sainz-Prestel V; Gonzalez-Espinoza L; Muñoz-Rodriguez MA; Tabikh A; Egido J; Ortiz A
Blood Purif; 2014; 38(3-4):224-33. PubMed ID: 25531119
[TBL] [Abstract][Full Text] [Related]
14. High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone.
Bro S; Brandi L; Olgaard K
Nephrol Dial Transplant; 1996 Aug; 11(8):1586-91. PubMed ID: 8856216
[TBL] [Abstract][Full Text] [Related]
15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
16. Cardiac troponin T elevation at dialysis initiation is associated with all-cause and cardiovascular mortality on dialysis in patients without diabetic nephropathy.
Hayashi T; Kimura T; Yasuda K; Sasaki K; Obi Y; Rakugi H; Isaka Y
Clin Exp Nephrol; 2017 Apr; 21(2):333-341. PubMed ID: 27178276
[TBL] [Abstract][Full Text] [Related]
17. Use of phosphate-binding agents is associated with a lower risk of mortality.
Cannata-Andía JB; Fernández-Martín JL; Locatelli F; London G; Gorriz JL; Floege J; Ketteler M; Ferreira A; Covic A; Rutkowski B; Memmos D; Bos WJ; Teplan V; Nagy J; Tielemans C; Verbeelen D; Goldsmith D; Kramar R; Martin PY; Wüthrich RP; Pavlovic D; Benedik M; Sánchez JE; Martínez-Camblor P; Naves-Díaz M; Carrero JJ; Zoccali C
Kidney Int; 2013 Nov; 84(5):998-1008. PubMed ID: 23823605
[TBL] [Abstract][Full Text] [Related]
18. Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study.
Fernández-Martín JL; Martínez-Camblor P; Dionisi MP; Floege J; Ketteler M; London G; Locatelli F; Gorriz JL; Rutkowski B; Ferreira A; Bos WJ; Covic A; Rodríguez-García M; Sánchez JE; Rodríguez-Puyol D; Cannata-Andia JB;
Nephrol Dial Transplant; 2015 Sep; 30(9):1542-51. PubMed ID: 25920921
[TBL] [Abstract][Full Text] [Related]
19. Low-calcium dialysate stimulates parathormone secretion and its long-term use worsens secondary hyperparathyroidism.
Fernández E; Borràs M; Pais B; Montoliu J
J Am Soc Nephrol; 1995 Jul; 6(1):132-5. PubMed ID: 7579066
[TBL] [Abstract][Full Text] [Related]
20. The impact of low and high dialysate calcium concentrations on cardiovascular disease and death in patients undergoing maintenance hemodialysis: a systematic review and meta-analysis.
Kamei K; Yamada S; Hashimoto K; Konta T; Hamano T; Fukagawa M
Clin Exp Nephrol; 2024 Jun; 28(6):557-570. PubMed ID: 38396314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
